Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Tampa, FL
NPI: 1376792911Primary Employer
Moffitt Medical Group
moffitt.org
HQ Phone
Get M.D. Farhad's Phone Numberphone_androidMobile
Get M.D. Farhad's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2015 - 2027
WV State Medical License
2011 - 2016
American Board of Internal Medicine
Hematology
American Board of Internal Medicine
Medical Oncology
H. Lee Moffitt Cancer Center
Blood and Marrow Transplant
2014 - 2015
West Virginia University
Fellowship • Hematology and Medical Oncology
2011 - 2014
Residency • Internal Medicine
2008 - 2011
Aga Khan Medical College
Medical School
Until 2005
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 50 | 205 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 22 | 41 |
Authors: Maria Sandoval, Sungjune Kim, Nicholas Figura, Jose Penagaricano, Peter Johnstone, Timothy Robinson, Casey Liveringhouse, Rawan Faramand, Michael Nieder
Journal: Technol Cancer Res Treat
Authors: Ariel Perez Perez, Frederick Locke, Taiga Nishihori, Sameh Gaballa, Julio Chavez, Bijal Shah
Journal: Blood Adv
Authors: Lia Perez, Nelli Bejanyan, Hugo Fernandez, Ryotaro Nakamura, Geoffrey Shouse, Salman Otoukesh, Stephen Forman, Haris Ali, Taiga Nishihori, Rawan Faramand, Shukaib Arslan, Hany Elmariah, Michael Nieder, Hien Liu, Hoda Pourhassan, Asmita Mishra, Claudio Anasetti, Joseph Pidala
Journal: Transplant Cell Ther
Lead Sponsor: Center for International Blood and Marrow Transplant Research
Collaborators: National Marrow Donor Program
Intervention / Treatment: DRUG: Busulfan, DRUG: Cyclophosphamide, DRUG: Melphalan, DRUG: Tacrolimus, DRUG: Mesna, DRUG: Mycophenolate Mofetil, DRUG: Fludarabine, RADIATION: Total-body irradiation, PROCEDURE: PBSC Hematopoietic Stem Cell Transplantation (HSCT), OTHER: Patient Reported Outcomes, DRUG: Post-Transplant Cyclophosphamide
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Intervention / Treatment: BIOLOGICAL: CD8 Depleted, Non-engrafting,HLA mismatched unrelated donor lymphocytes, DRUG: Standard of Care Chemotherapy
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: DRUG: Sirolimus, DRUG: Tacrolimus, DRUG: BMS-986004
Publication Date: 2024-08-03